市場調査レポート

商品コード

1722267

糖鎖生物学の市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別、地域別 - 産業予測 2025～2032年

Glycobiology Market Size, Share, and Growth Analysis, By Product Type (Enzymes, Instruments), By Application (Diagnostics, Drug Discovery and Development), By End User, By Region, And Segment Forecast, 2025-2032

出版日: 2025年05月04日
発行: SkyQuest
ページ情報: 英文 186 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 769,984円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 900,736円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,031,488円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.28円

全表示
概要
目次

概要

サンプル依頼リストに入れる

糖鎖生物学の世界市場規模は2023年に20億米ドルと評価され、予測期間（2025-2032年）のCAGRは14.9%で、2024年の23億米ドルから2032年には69億8,000万米ドルに成長する見通しです。

バイオ医薬品業界は、個別化医療や標的治療の重視によって大きな成長を遂げており、細胞や分子の動態、特に複雑な糖鎖構造に対する深い洞察が必要とされています。この需要は、製薬企業やバイオテクノロジー企業の研究開発投資の増加を後押ししており、糖鎖機能研究を促進する質量分析計やハイスループット糖鎖分析などの分析技術の進歩に支えられています。特にがん、感染症、自己免疫疾患などの疾病診断および治療における糖鎖の理解は、政府による規制の支援とともに、産業界と学術機関の共同努力によって進展しています。しかし、糖鎖固有の構造の複雑さ、訓練を受けた人材の不足、高コスト、新興経済諸国における限られたリソースなどの課題が、ヘルスケア分野におけるグライコミクスの進展と採用を妨げています。

市場概要
酵素
- グリコシダーゼ
- ノイラミニダーゼ
- グリコシルトランスフェラーゼ
- シアリルトランスフェラーゼ
- その他
機器
- 質量分析計
- HPLC
- MALDI-TOF
- アレイシステム
- その他
炭水化物
- オリゴ糖
- 多糖類
- その他の炭水化物
キット
- グリカン標識キット
- グリカン精製キット
- グリカン放出キット
- その他
試薬
- 糖タンパク質
- 単糖類
- オリゴ糖
- その他
その他

糖鎖生物学市場規模：用途別& CAGR（2025-2032）

市場概要
診断
医薬品の発見と開発
腫瘍学
免疫学
その他の用途

糖鎖生物学市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
製薬・バイオテクノロジー企業
契約調査機関
その他のエンドユーザー

糖鎖生物学市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Thermo Fisher Scientific（US）
New England Biolabs（US）
Merck KGaA（Germany）
Promega Corporation（US）
Waters Corporation（US）
Takara Bio Inc,（Japan）
Bio-Techne（US）
Agilent Technologies（US）
Sumitomo Bakelite Co. Ltd.（Japan）
Bruker Corporation（US）
Shimadzu Corporation（Japan）
Danaher Corporation（US）
AMS Bio（UK）
Ludger Ltd（UK）
Z Biotech, LLC（US）
Chemily Glycoscience（US）
CD BioGlyco（US）
GlycoDiag（France）
Kode Biotech Limited（New Zealand）
Glyxera GmBH（Germany）

結論と提言

Product Code: SQMIG35H2335

Global Glycobiology Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 6.98 billion by 2032, growing at a CAGR of 14.9% during the forecast period (2025-2032).

The biopharmaceutical industry is experiencing significant growth driven by an emphasis on personalized medicine and targeted therapies, necessitating deeper insights into cellular and molecular dynamics, particularly complex carbohydrate structures. This demand is propelling increased investment in R&D among pharma and biotech firms, supported by advancements in analytical technologies like mass spectrometry and high-throughput glycan analysis facilitating glycan function research. Collaborative efforts between industry and academic institutions, alongside supportive government regulations, are advancing the understanding of glycans in disease diagnostics and treatment, particularly in cancer, infectious, and autoimmune diseases. However, challenges such as the inherent structural complexity of glycans, a shortage of trained personnel, high costs, and limited resources in developing economies hinder progress and adoption of glycomics in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glycobiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glycobiology Market Segments Analysis

Global Glycobiology Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Enzymes, Instruments, Carbohydrates, Kits, Reagents and Others. Based on Application, the market is segmented into Diagnostics, Drug Discovery and Development, Oncology, Immunology and Other Applications. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glycobiology Market

The global glycobiology market is significantly influenced by substantial government investments in glycomics research aimed at improving public health. For example, Australia allocated over $10 billion for scientific research innovation between 2017 and 2018, while Ireland invested $5.6 billion in 2015 to boost research activities and increase its scientific workforce from 25,000 to 40,000. Such financial commitments are crucial as they enhance research capabilities and foster advancements in the field. Consequently, these investments contribute to the steady growth of the glycobiology market, highlighting the importance of governmental support in advancing scientific research and development.

Restraints in the Global Glycobiology Market

One of the primary constraints facing the global glycobiology market is the high cost associated with glycobiology research instruments, particularly high-performance liquid chromatography (HPLC) systems and mass spectrometers. These advanced tools can cost anywhere from hundreds of thousands to millions of dollars, making them prohibitively expensive for smaller research laboratories and emerging biotechnology firms. Furthermore, the specialized reagents required for glycan analysis add to the financial burden, limiting the widespread adoption of glycomics technologies across the industry. This financial barrier hinders innovation and can stymie progress in glycobiology research and development.

Market Trends of the Global Glycobiology Market

The Global Glycobiology market is witnessing significant growth, fueled by the rising demand for personalized medicine. As the precision medicine market in Europe is projected to surge from USD 16.72 billion in 2024 to USD 38.26 billion by 2032, the focus on individualized treatment protocols strengthens the role of glycomics. By harnessing unique glycan profiles, glycobiology facilitates the creation of disease-specific drugs and therapies, thereby enhancing therapeutic outcomes. This trend reflects a broader healthcare shift towards more tailored medical solutions, positioning glycobiology at the forefront of innovative therapeutic advancements and contributing to the overall expansion of the life sciences sector globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Glycobiology Market Size by Product Type & CAGR (2025-2032)

Market Overview
Enzymes
- Glycosidases
- Neuraminidases
- Glycosyltransferases
- Sialyltransferases
- Others
Instruments
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array Systems
- Others
Carbohydrates
- Oligosaccharides
- Polysaccharides
- Other Carbohydrates
Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
Others

Global Glycobiology Market Size by Application & CAGR (2025-2032)

Market Overview
Diagnostics
Drug Discovery and Development
Oncology
Immunology
Other Applications

Global Glycobiology Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users

Global Glycobiology Market Size & CAGR (2025-2032)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc, (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sumitomo Bakelite Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AMS Bio (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ludger Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Z Biotech, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chemily Glycoscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CD BioGlyco (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlycoDiag (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kode Biotech Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glyxera GmBH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments